0.69 | 10.63%
| Price and Volume | |
|---|---|
| Recent Price | 6.49 |
| 52 Week High | 8.39 |
| 52 Week Low | 4.12 |
| Avg. Daily Vol. (Mil) | 0.12 |
| Beta (3 year) | 1.06 |
| Share Related Items | |
| Mkt Cap (Mil) | 213.21 |
| Shares Out (Mil) | 32.85 |
| Float (Mil) | 14.12 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 9.20 |
| Current Ratio | 9.90 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 23.20 |
| Price/Sales | 5.83 |
| Price/Book | 4.75 |
| Price/Cash Flow | 20.70 |
| Per Share Data | |
| Earnings | 0.28 |
| Sales | 1.11 |
| Book Value | 1.37 |
| Cash Flow | 0.31 |
| Business Summary | |
|---|---|
| A stem cell therapeutic company, which is focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas. | |
| General Information | |
| 7015 Albert Einstein Drive
Columbia, MD 21046 |
|
| www.osiristx.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 54 | |
| CEO: Dr. C. Randal Mills,PhD | |
| Short Interest | |
| Current Month (Mil) | 2.57 |
| Previous Month (Mil) | 2.52 |
| Short Interest Ratio (Days) | 32.70 |
| Management Effectiveness | |
| Return on Equity | 21.30 |
| Return on Assets | 19.10 |
| Return on Investments | 21.30 |
| Profitability | |
| Gross Margin | 99.50 |
| EBIT Margin | 26.30 |
| Profit Margin | 26.20 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,437.23 | 1,318.09 | 2,834.30 | 16.47 |
Oil *
103.97
|
|
DOWN
143.46 |
DOWN
14.33 |
DOWN
36.69 |
DOWN
0.84 |
10 Yr
1.65%
SPDR Gold
149.80
|
|
-1.14%
|
-1.08%
|
-1.28%
|
-4.85%
|
Data delayed 20 minutes |
Connect with TheStreet